Gotowe bibliografie tematyczne / Vaccines Effectiveness

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji
  6. Raporty organizacyjne

Gotowa bibliografia na temat „Vaccines Effectiveness”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 28 stycznia 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Vaccines Effectiveness”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Vaccines Effectiveness"

1

Trombetta, Claudia Maria, Otfried Kistner, Emanuele Montomoli, Simonetta Viviani, and Serena Marchi. "Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines." Vaccines 10, no. 5 (May 1, 2022): 714. http://dx.doi.org/10.3390/vaccines10050714.

Pełny tekst źródła
Streszczenie:
Influenza is a vaccine preventable disease and vaccination remains the most effective method of controlling the morbidity and mortality of seasonal influenza, especially with respect to risk groups. To date, three types of influenza vaccines have been licensed: inactivated, live-attenuated, and recombinant haemagglutinin vaccines. Effectiveness studies allow an assessment of the positive effects of influenza vaccines in the field. The effectiveness of current influenza is suboptimal, being estimated as 40% to 60% when the vaccines strains are antigenically well-matched with the circulating vir
Style APA, Harvard, Vancouver, ISO itp.
2

Helena De Oliveira, Lucia, Barbara Jauregui, Ana Flavia Carvalho, and Norberto Giglio. "Impact and effectiveness of meningococcal vaccines: a review." Revista Panamericana de Salud Pública 41 (December 20, 2017): 1. http://dx.doi.org/10.26633/rpsp.2017.158.

Pełny tekst źródła
Streszczenie:
Objectives.To summarize and critically evaluate the evidence on the impact and effectiveness of meningococcal vaccination programs around the world in order to inform decisionmaking in Latin America and the Caribbean.Methods.A review of the literature was conducted following several components of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed Central® was searched for papers published in any language from January 1999 – March 2017.Results.In all, 32 studies were included, most of which evaluated the meningococcal C conjugate vaccine. Fourteen studies
Style APA, Harvard, Vancouver, ISO itp.
3

Pálinkás, Anita, and János Sándor. "Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary: Nationwide Retrospective Cohort Study." Vaccines 10, no. 7 (June 24, 2022): 1009. http://dx.doi.org/10.3390/vaccines10071009.

Pełny tekst źródła
Streszczenie:
Our investigation aimed to describe the all-cause mortality rates by COVID-19 vaccination groups in Hungary for an epidemic period (1 April 2021–20 June 2021) and a nonepidemic period (21 June 2021–15 August 2021), and to determine the vaccines’ effectiveness in preventing all-cause mortality utilizing nonepidemic effectiveness measures to adjust for the healthy vaccinee effect (HVE). Sociodemographic status, comorbidity, primary care structural characteristics, and HVE-adjusted survival difference between fully vaccinated and unvaccinated cohorts in the epidemic period had been computed by Co
Style APA, Harvard, Vancouver, ISO itp.
4

Kamolratanakul, Supitcha, and Punnee Pitisuttithum. "Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer." Vaccines 9, no. 12 (November 30, 2021): 1413. http://dx.doi.org/10.3390/vaccines9121413.

Pełny tekst źródła
Streszczenie:
Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15 HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers. However, cervical cancer remains one of the most common cancers in women, especially in developing countries. Three HPV vaccines have been licensed: bivalent (Cervarix, GSK, Rixensart, Belgium), quadrivalent (Merck, Sharp & Dome (Merck & Co, Whitehouse Station, NJ, USA)), and nonavalent (Merck, Sharp & Dome (Merck & Co, Whitehouse Station, NJ, USA)). The current HPV vaccine recommendations apply to 9 years
Style APA, Harvard, Vancouver, ISO itp.
5

Izurieta, Hector S., Yoganand Chillarige, Jeffrey Kelman, Yuqin Wei, Yun Lu, Wenjie Xu, Michael Lu, et al. "Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019." Journal of Infectious Diseases 222, no. 2 (February 26, 2020): 278–87. http://dx.doi.org/10.1093/infdis/jiaa080.

Pełny tekst źródła
Streszczenie:
Abstract Background Studies among individuals ages ≥65 years have found a moderately higher relative vaccine effectiveness (RVE) for the high-dose (HD) influenza vaccine compared with standard-dose (SD) products for most seasons. Studies during the A(H3N2)-dominated 2017–2018 season showed slightly higher RVE for the cell-cultured vaccine compared with SD egg-based vaccines. We investigated the RVE of influenza vaccines among Medicare beneficiaries ages ≥65 years during the 2018–2019 season. Methods This is a retrospective cohort study using inverse probability of treatment weighting and Poiss
Style APA, Harvard, Vancouver, ISO itp.
6

Diogo José Horst and Charles Adriano Duvoisin. "The doubtful effectiveness of the COVID-19 vaccine." GSC Biological and Pharmaceutical Sciences 15, no. 2 (May 30, 2021): 151–57. http://dx.doi.org/10.30574/gscbps.2021.15.2.0132.

Pełny tekst źródła
Streszczenie:
A COVID-19 pandemic has erupted around the world. World Health Organization (WHO) and allies are racing to create and deploy safe and effective vaccines as they work together to monitor the pandemic, advise on crucial measures, and distribute essential medical resources to those in need. Vaccines save millions of lives, by training the body's natural defenses, the immune system, to identify and combat the viruses and bacteria they are intended to combat. This review article presents the status of COVID-19 vaccines evaluated by the WHO Emergency Use Listing (EUL) assessment process and those li
Style APA, Harvard, Vancouver, ISO itp.
7

Knight-Jones, T. J. D., K. Edmond, S. Gubbins, and D. J. Paton. "Veterinary and human vaccine evaluation methods." Proceedings of the Royal Society B: Biological Sciences 281, no. 1784 (June 7, 2014): 20132839. http://dx.doi.org/10.1098/rspb.2013.2839.

Pełny tekst źródła
Streszczenie:
Despite the universal importance of vaccines, approaches to human and veterinary vaccine evaluation differ markedly. For human vaccines, vaccine efficacy is the proportion of vaccinated individuals protected by the vaccine against a defined outcome under ideal conditions, whereas for veterinary vaccines the term is used for a range of measures of vaccine protection. The evaluation of vaccine effectiveness , vaccine protection assessed under routine programme conditions, is largely limited to human vaccines. Challenge studies under controlled conditions and sero-conversion studies are widely us
Style APA, Harvard, Vancouver, ISO itp.
8

Stöckli, Sabrina, Anna Katharina Spälti, Joseph Phillips, Florian Stoeckel, Matthew Barnfield, Jack Thompson, Benjamin Lyons, Vittorio Mérola, Paula Szewach, and Jason Reifler. "Which vaccine attributes foster vaccine uptake? A cross-country conjoint experiment." PLOS ONE 17, no. 5 (May 4, 2022): e0266003. http://dx.doi.org/10.1371/journal.pone.0266003.

Pełny tekst źródła
Streszczenie:
Why do people prefer one particular COVID-19 vaccine over another? We conducted a pre-registered conjoint experiment (n = 5,432) in France, Germany, and Sweden in which respondents rated the favorability of and chose between pairs of hypothetical COVID-19 vaccines. Differences in effectiveness and the prevalence of side-effects had the largest effects on vaccine preferences. Factors with smaller effects include country of origin (respondents are less favorable to vaccines of Chinese and Russian origin), and vaccine technology (respondents exhibited a small preference for hypothetical mRNA vacc
Style APA, Harvard, Vancouver, ISO itp.
9

Erofeeva, M. K., M. A. Stukova, E. V. Shakhlanskaya, Zh V. Buzitskaya, V. L. Maksakova, T. I. Krainova, M. M. Pisareva, A. B. Popov, M. G. Pozdnjakova, and D. A. Lioznov. "Evaluation of the Preventive Effectiveness of Influenza Vaccines in the Epidemic Season 2019–2020 in St. Petersburg." Epidemiology and Vaccinal Prevention 20, no. 5 (November 5, 2021): 52–60. http://dx.doi.org/10.31631/2073-3046-2021-20-5-52-60-52-60.

Pełny tekst źródła
Streszczenie:
Background. The vaccine is the best available instrument to prevent influenza and reduce the risks of major disease complications and mortality. The vaccine effectiveness during the influenza season depends on a number of factors: (1) a person vaccinated (their age and health status); (2) the vaccine formulation; (3) types and subtypes of the circulating viruses; (4) vaccination timeline, as the immune response fades over time. An influenza vaccine can yield different effectiveness in people who have been infected or vaccinated previously and in those who have not been yet exposed to the circu
Style APA, Harvard, Vancouver, ISO itp.
10

Rajaram, Sankarasubramanian, Constantina Boikos, Daniele K. Gelone, and Ashesh Gandhi. "Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing." Therapeutic Advances in Vaccines and Immunotherapy 8 (January 2020): 251513552090812. http://dx.doi.org/10.1177/2515135520908121.

Pełny tekst źródła
Streszczenie:
Influenza continues to cause severe illness in millions and deaths in hundreds of thousands annually. Vaccines are used to prevent influenza outbreaks, however, the influenza virus mutates and annual vaccination is required for optimal protection. Vaccine effectiveness is also affected by other potential factors such as the human immune system, a mismatch with the chosen candidate virus, and egg adaptation associated with egg-based vaccine production. This article reviews the influenza vaccine development process and describes the implications of the changes to the cell-culture process and vac
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Vaccines Effectiveness"

1

Ming, Wai-kit, and 明偉傑. "Effectiveness of universal rotavirus vaccination: a literature review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B50222995.

Pełny tekst źródła
Streszczenie:
Objectives This study focuses on the evaluation of the use of vaccine in the prevention of severe acute gastroenteritis in the community in the literature. The objectives of this project report include an in depth review of the effectiveness and cost effectiveness of rotavirus vaccination for severe acute gastroenteritis in low and middle income countries (developing countries). Methods Publications were identified using computerized bibliographic searches in PubMed (for the period from October 1994 to July 2012). The keywords “effective*”, “vaccin*”, “rotavirus” , “Randomized controlled
Style APA, Harvard, Vancouver, ISO itp.
2

Boros, Christina Ann. "Factors affecting the immunogenicity and protective efficacy of routine childhood immunisations." Title page, contents and abstract only, 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phb736.pdf.

Pełny tekst źródła
Streszczenie:
Includes list of publications arising from the thesis. Bibliography: leaves 327-341. Examines the effect of adverse storage on the immunogenicity of pertussis, diphtheria and tetanus vaccines, the protective efficacy of pertussis vaccines and the effect of premature birth on antibody response to routine childhood immunisations.
Style APA, Harvard, Vancouver, ISO itp.
3

Yuen, Wing-mei, and 阮泳薇. "Systematic review on the cost effectiveness of human papillomavirus vaccination in Asia and its implication in Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48427329.

Pełny tekst źródła
Streszczenie:
Background: Human papillomavirus vaccination is newly developed in this decade. There are 2 types of vaccines. Bivalent vaccine targets on HPV types 16, 18 to prevent cervical cancer. Quadrivalent vaccine target on HPV type 6, 11, 16, 18 to prevent genital warts and cervical cancer. England has adopted a population –based HPV vaccination program. In attempt to find out the worthiness to implement the population-based vaccination program in Hong Kong, this project reviewed 15 cost-effectiveness analyses in Asian countries. Asian countries may have the similar characteristics, such as culture,
Style APA, Harvard, Vancouver, ISO itp.
4

Cheung, Ka-mei Camy, and 張嘉楣. "The cost-effectiveness of human pappillomavirus vaccines in men : a systematic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193771.

Pełny tekst źródła
Streszczenie:
Background Human Papillomavirus (HPV) infection is the most common sexually transmitted infection worldwide. It is the leading cause of genital warts and cervical cancer, and is strongly associated with oropharyngeal and other anogenital cancers. To date, two prophylactic HPV vaccines are available, both of which have shown high efficacies in protection against vaccine-type HPV infection and HPV-associated diseases in both males and females. Despite the proven efficacies, male vaccination has not been included in any national vaccination programme worldwide. In Hong Kong, vaccine uptake remai
Style APA, Harvard, Vancouver, ISO itp.
5

Lau, Tin-wai. "Effectiveness of influenza vaccine among elderly people living in residential care homes during outbreak situations." Click to view the E-thesis via HKUTO, 2005. http://sunzi.lib.hku.hk/hkuto/record/b39724177.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Mezones, Holguín Edward, Díaz Rafael Bolaños, Víctor Fiestas, César Sanabria, Aguado Alfonso Gutiérrez, Fabián Fiestas, Víctor J. Suárez, Morales Alfonso J. Rodríguez, and Adrian V. Hernández. "Cost-effectiveness analysis of pneumococcal conjugate vaccines in preventing pneumonia in Peruvian children." The Journal of Infection in Developing Countries, 2015. http://hdl.handle.net/10757/337985.

Pełny tekst źródła
Streszczenie:
emezones@gmail.com<br>Introduction: Pneumococcal pneumonia (PP) has a high burden of morbimortality in children. Use of pneumococcal conjugate vaccines (PCVs) is an effective preventive measure. After PCV 7-valent (PCV7) withdrawal, PCV 10-valent (PCV10) and PCV 13-valent (PCV13) are the alternatives in Peru. This study aimed to evaluate cost effectiveness of these vaccines in preventing PP in Peruvian children <5 yearsold. Methodology: A cost-effectiveness analysis was developed in three phases: a systematic evidence search for calculating effectiveness; a cost analysis for vaccine strategies
Style APA, Harvard, Vancouver, ISO itp.
7

Mezones, Holguín Edward, Aybara Carlos Canelo, Clark Andrew David, Janusz Cara Bess, Bárbara Jaúregui, Palza Seimer Escobedo, Adrian V. Hernandez, et al. "Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru." Elsevier B.V, 2015. http://hdl.handle.net/10757/582635.

Pełny tekst źródła
Streszczenie:
Objective To evaluate the cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine (PCV10) versus the 13-valent PCV (PCV13) to the National Immunization Schedule in Peru for prevention of pneumococcal disease (PD) in children <5 years of age. Methods The integrated TRIVAC vaccine cost-effectiveness model from the Pan American Health Organization's ProVac Initiative (version 2.0) was applied from the perspective of the Government of Peru. Twenty successive cohorts of children from birth to 5 years were evaluated. Clinical outcomes were pneumococcal pneumonia (PP),
Style APA, Harvard, Vancouver, ISO itp.
8

Marlow, Robin. "Assessing the impact and cost-effectiveness of rotavirus vaccines in the United Kingdom." Thesis, University of Bristol, 2016. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.705468.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Sharma, Aditya. "Cost-effectiveness of Hepatitis A and Hepatitis B Vaccination for Jail Inmates." Yale University, 2008. http://ymtdl.med.yale.edu/theses/available/etd-08272007-114829/.

Pełny tekst źródła
Streszczenie:
Despite evidence that viral hepatitis poses a significant risk to public health, universal vaccination has not yet been implemented. The risk for viral hepatitis infection is particularly high among injection drug users and other individuals who do not attend regular health care visits. Jails provide a structural opportunity to vaccinate these high risk individuals. HAV and HBV vaccines administered on an accelerated three week schedule could dramatically decrease the lifetime risk for contracting viral hepatitis among jail detainees. Assuming that 75% of detainees would accept vaccination, 33
Style APA, Harvard, Vancouver, ISO itp.
10

Koh, Naoko. "Cost-benefit analysis of influenza vaccination for children in Hong Kong." Thesis, Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B31971866.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Vaccines Effectiveness"

1

Sullivan, Louis Wade. Cost-effectiveness demonstration of Medicare coverage of influenza vaccine: Report to Congress. [Washington, D.C.?: Dept. of Health and Human Services], 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Shalala, Donna E. Medicare influenza vaccine demonstration: Report to Congress. [Washington, D.C.?: Dept. of Health and Human Services], 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Chan, Kwai-Cheung. Medical readiness: Issues concerning the anthrax vaccine : statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Subcommittee on National Security, Veterans' Affairs, and International Relations, Committee on Government Reform, House of Representatives. Washington, D.C. (P.O. Box 37050, Washington, D.C. 20013): The Office, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Chan, Kwai-Cheung. Medical readiness: Safety and efficacy of the anthrax vaccine : statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Subcommittee on National Security, Veterans' Affairs, and International Relations, Committee on Government Reform, House of Representatives. Washington, D.C: The Office, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Chan, Kwai-Cheung. Medical readiness: Safety and efficacy of the anthrax vaccine : statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Subcommittee on National Security, Veterans' Affairs, and International Relations, Committee on Government Reform, House of Representatives. Washington, D.C: The Office, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Taehak, Sŏul Taehakkyo Ŭikwa, ред. Inpʻŭlluenja paeksin (soa) yuyongsŏng pʻyŏngka yŏnʼgu: Yŏnʼgu kyŏlgwa pogosŏ = Evaluation of efficacy of influenza vaccine in children. [Seoul]: Sikpʻum Ŭiyakpʻum Anjŏnchʻŏng, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Communicating about Vaccine Safety: Guidelines to help health workers communicate with parents, caregivers, and patients. Pan American Health Organization, 2021. http://dx.doi.org/10.37774/9789275122822.

Pełny tekst źródła
Streszczenie:
Vaccines save between 2 million and 3 million lives each year and protect the entire population from more than a dozen life-threatening diseases. Thanks to vaccination, smallpox was eradicated in 1980, and we are on track to eradicate polio. However, despite great strides in the control of measles, one of the most contagious diseases known, the last few years have unfortunately seen an increase in cases. This is why high vaccination coverage—95% or more—is needed, posing a major technical and communication challenge for health workers. Studies show that telling people about the quality, safety
Style APA, Harvard, Vancouver, ISO itp.
8

Barker, Richard. Lessons from the last 20 years. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198737780.003.0004.

Pełny tekst źródła
Streszczenie:
A review of a dozen case examples of pharmaceutical innovation—from HIV to stomach ulcers—and others from vaccines, diagnostics, and medical devices give many pointers to the way forward to more productive and sustainable medical innovation. A sense of urgency, strong patient and public engagement, regulatory flexibility, cross-sector collaboration, and creativity on payment mechanisms all need to be built need to our new models, as we move into an era of precision medicine. We can also learn from other industries—from aerospace to IT—greater innovation around increased cost-effectiveness.
Style APA, Harvard, Vancouver, ISO itp.
9

Rouse, Carolyn. Evidence of What? Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190465285.003.0010.

Pełny tekst źródła
Streszczenie:
This chapter interrogates an important vogue in the field of African development. Evidence-based approaches to health care, which are being used increasingly, fail to take into account social and cultural factors affecting individuals' health. Bed nets and vaccines are helpful in reducing malaria-related mortality rates in African countries, but nature and culture are indivisible in health and wellness. Malaria and sickle cell anemia are most commonly analyzed using evidence-based approaches, like many medical issues, although there are numerous social factors to be taken into account in their
Style APA, Harvard, Vancouver, ISO itp.
10

R, Berndt Ernst, and National Bureau of Economic Research., eds. Advanced purchase commitments for a malaria vaccine: Estimating costs and effectiveness. Cambridge, MA: National Bureau of Economic Research, 2005.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Części książek na temat "Vaccines Effectiveness"

1

Myers, Evan R. "Cost-Effectiveness of HPV Vaccines." In Emerging Issues on HPV Infections, 235–41. Basel: KARGER, 2006. http://dx.doi.org/10.1159/000092759.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Whitney, Cynthia G., and Matthew R. Moore. "Direct and Indirect Effectiveness and Safety of Pneumococcal Conjugate Vaccine in Practice." In Pneumococcal Vaccines, 351–68. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555815820.ch24.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Biggers, John D. "The Potential Effectiveness and Safety of Second Generation Vaccines." In Immunological Approaches to Contraception and Promotion of Fertility, 203–7. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4684-5140-5_24.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Lehtinen, Matti, Pekka Nieminen, Dan Apter, Proscowa Namujju, Kari Natunen, Mohsin Rana, and Jorma Paavonen. "Immunogenicity, Efficacy, Effectiveness and Overall Impact of HPV Vaccines." In HPV and Cervical Cancer, 257–72. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-1988-4_10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Bora, Ajitabh, Hemanta Kumar Gogoi, and Vijay Veer. "Molecular Farming for Production of Biopharmaceuticals and Edible Vaccines in Plants." In Herbal Insecticides, Repellents and Biomedicines: Effectiveness and Commercialization, 205–16. New Delhi: Springer India, 2016. http://dx.doi.org/10.1007/978-81-322-2704-5_11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Mueller, Siguna. "The Challenge of Evaluating Vaccine Safety and Effectiveness." In Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2, 131–62. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-18903-6_5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Hahné, Susan, Kaatje Bollaerts, and Paddy Farrington. "Vaccine effectiveness." In Vaccination Programmes, 223–44. London: Routledge, 2021. http://dx.doi.org/10.4324/9781315166414-16.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Nauta, Jozef. "Vaccine Effectiveness Studies." In Springer Series in Pharmaceutical Statistics, 129–50. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-37693-2_9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Hahné, Susan, Kaatje Bollaerts, and Paddy Farrington. "Estimating vaccine effectiveness." In Vaccination Programmes, 289–308. London: Routledge, 2021. http://dx.doi.org/10.4324/9781315166414-19.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Hahné, Susan, Kaatje Bollaerts, and Paddy Farrington. "Estimating vaccine effectiveness." In Vaccination Programmes, 245–63. London: Routledge, 2021. http://dx.doi.org/10.4324/9781315166414-17.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Vaccines Effectiveness"

1

Zughaier, Susu. "High Vaccine Coverage is Crucial for Preventing the Spread of Infectious Diseases During Mass Gathering." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0138.

Pełny tekst źródła
Streszczenie:
Background: Vaccines are the most cost-effective intervention in public health as they prevent the spread of highly contagious infectious diseases. Because of vaccine implementation and high coverage, Measles was eradicated in 2000, however the recent reappearance of measles in the United States, Europe and globally is alarming. The resurgence of Measles, Diphtheria and Mumps is due to a reduction in vaccine coverage and herd immunity. Vaccine hesitant parents, antivaxxers, and fake news on vaccines are driving the surge in those infectious diseases. The World Health Organization issued the Gl
Style APA, Harvard, Vancouver, ISO itp.
2

"Emergence of SARS-CoV-2 Variant of Concern Omicron: Biological Features and Genomic Concern." In International Conference on Public Health and Humanitarian Action. International Federation of Medical Students' Associations - Jordan, 2022. http://dx.doi.org/10.56950/itrx2370.

Pełny tekst źródła
Streszczenie:
Abstract Corona virus infection is a worldwide health threat that has infected a substantial portion of the world's population and is caused by SARS-CoV-2. It is the natural tendency of a virus to change the genetic makeup through the point mutation, and such viruses are called the variant of the original virus. SARS-CoV-2 virus also undergoes such mutation (may be one or more and distinct from other) over time, and many genetically diverse variant has risen. Such variants might be of variants of concern (VOC) and variant of interest (VOI) based on the differences in virulence, transmissibilit
Style APA, Harvard, Vancouver, ISO itp.
3

Ditamy, Aldila, Beatrice Sasmita, Bella Edytha Kurniawan, I. Putu Indra Widia Kumara, Nathanael Victorius, Shreyasi Sarkar, and Bagus Mulyawan. "The Effectiveness, Side Effects, and Implementation Between Variation of COVID-19 Vaccines in Indonesia." In 3rd Tarumanagara International Conference on the Applications of Social Sciences and Humanities (TICASH 2021). Paris, France: Atlantis Press, 2022. http://dx.doi.org/10.2991/assehr.k.220404.303.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Ignatova, G., V. Antonov, and E. Blinova. "Effectiveness of Joint or Sequential Vaccination of Pneumococcal and Flu Vaccines in Chronic Obstructive Pulmonary Disease Patients." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3317.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Xiao, Yichen, Han-Ching Ou, Haipeng Chen, Van Thieu Nguyen, and Long Tran-Thanh. "Sequential Vaccine Allocation with Delayed Feedback." In Thirty-First International Joint Conference on Artificial Intelligence {IJCAI-22}. California: International Joint Conferences on Artificial Intelligence Organization, 2022. http://dx.doi.org/10.24963/ijcai.2022/722.

Pełny tekst źródła
Streszczenie:
In this work we consider the problem of how to best allocate a limited supply of vaccines in the aftermath of an infectious disease outbreak by viewing the problem as a sequential game between a learner and an environment (specifically, a bandit problem). The difficulty of this problem lies in the fact that the payoff of vaccination cannot be directly observed, making it difficult to compare the relative effectiveness of vaccination on different population groups. Currently used vaccination policies make recommendations based on mathematical modelling and ethical considerations. These policies
Style APA, Harvard, Vancouver, ISO itp.
6

Sikjær, M., M. S. Wik, S. S. Stensholt, O. Hilberg, and A. Løkke. "Effectiveness of the pneumococcal polysaccharide and conjugated vaccines in elderly and high-risk populations in preventing invasive pneumococcal disease: A systematic search and review of the literature." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.793.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Capão, Artur, Braulia Caetano, Paola Resende, Milene Miranda, David Brown, Marilda Siqueira, and Cristiana Garcia. "Effectiveness of 2018 trivalent influenza vaccine on healthcare professionals." In IV International Symposium on Immunobiologicals & VII Seminário Anual Científico e Tecnológico. Instituto de Tecnologia em Imunobiológicos, 2019. http://dx.doi.org/10.35259/isi.sact.2019_32545.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Elbashir, Israa, Aisha Aisha Nasser J. M. Al-Saei, Paul Thornalley, and Naila Rabbani. "Evaluation of antiviral activity of Manuka honey against SARS-CoV-2." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0113.

Pełny tekst źródła
Streszczenie:
Background and aims: In 2020 a global pandemic was declared caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2). The pandemic is still ongoing and continues to cause considerable mortality and morbidity world-wide and new variants of the virus are emerging. Rapid development and rollout of vaccines for SARS-CoV-2 is in progress to counter the pandemic but has been tempered by the emergence of new SARS-CoV-2 variants, many of which exhibit reduced vaccine effectiveness. To date there is no approved antiviral treatment for coronavirus disease 2019 (COVID-19). Several studies
Style APA, Harvard, Vancouver, ISO itp.
9

Adami, Giovanni, Angelo Fassio, Giovanni Orsolini, Alessandro Giollo, Davide Gatti, and Maurizio Rossini. "OP0230 EFFECTIVENESS OF INFLUENZA VACCINE IN TNF INHIBITORS TREATED PATIENTS." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.3088.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Vasileiou, Eleftheria, Colin Simpson, Aziz Sheikh, and Chris Butler. "Seasonal influenza vaccine effectiveness in people with asthma: A systematic review." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa4205.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Vaccines Effectiveness"

1

Ketata, Imen, Rahma Sellami, Marwa Gargouri, Leila Zrelli, Hajer Azzouzi, and Houda Ghorbel. Effectiveness of COVID-19 vaccines in older adults in South Tunisia-Gabes. Peeref, October 2022. http://dx.doi.org/10.54985/peeref.2210p5297898.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Roldan de Jong, Tamara. Rapid Review: Perceptions of COVID-19 Vaccines in South Africa. SSHAP, April 2022. http://dx.doi.org/10.19088/sshap.2021.021.

Pełny tekst źródła
Streszczenie:
As of April 19, 2021, South Africa has recorded 1.56 million COVID-19 cases and almost 54,000 deaths - more than any other country on the African continent. The country has begun the national rollout of the Johnson &amp; Johnson (J&amp;J) COVID-19 vaccine, with over 292 thousand doses administered it aims to achieve herd immunity by vaccinating at least 67 percent of its population (around 40 million people) by the end of 2021. The government suspended its initial rollout of the AstraZeneca (AZ) vaccine due to concerns over its effectiveness, particularly against the new B.1.351 variant, which
Style APA, Harvard, Vancouver, ISO itp.
3

Millington, Kerry A. Protecting and Promoting Systems for Essential Health Services During Rollout of COVID-19 Tools. Institute of Development Studies (IDS), May 2021. http://dx.doi.org/10.19088/k4d.2021.084.

Pełny tekst źródła
Streszczenie:
The COVID-19 pandemic has had a tremendous negative impact on economies of most countries around the world. COVID-19 has disrupted the ability of health systems to deliver on essential health services and has also exposed pre-existing vulnerabilities and inequities in public health systems. According to a key informant survey conducted by WHO, over one year into the COVID-19 pandemic, there still exist substantial disruptions to essential health services. This rapid review examines evidence on successful interventions that could enable adaptive approaches to help manage and respond future pand
Style APA, Harvard, Vancouver, ISO itp.
4

Berndt, Ernst, Rachel Glennerster, Michael Kremer, Jean Lee, Ruth Levine, Georg Weizsacker, and Heidi Williams. Advanced Purchase Commitments for a Malaria Vaccine: Estimating Costs and Effectiveness. Cambridge, MA: National Bureau of Economic Research, May 2005. http://dx.doi.org/10.3386/w11288.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Alsan, Marcella, and Sarah Eichmeyer. Experimental Evidence on the Effectiveness of Non-Experts for Improving Vaccine Demand. Cambridge, MA: National Bureau of Economic Research, March 2021. http://dx.doi.org/10.3386/w28593.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Butler, Nadia, and Soha Karam. Key Considerations for Integrating COVID-19 Vaccination Services: Insights from Iraq and Syria for the MENA Region. SSHAP, September 2022. http://dx.doi.org/10.19088/sshap.2022.034.

Pełny tekst źródła
Streszczenie:
With the COVID-19 pandemic well into its third year, governments and response partners are recognising that it no longer makes sense for COVID-19 services, including vaccination, to exist in isolation. There is growing recognition of the potential for integration with other services as the way forward for COVID-19 vaccination. This has recently begun to occur in various countries, but until now, there has been little evidence available as to the success of these initiatives. Service delivery integration occurs where “managerial or operational changes to health systems bring together inputs, de
Style APA, Harvard, Vancouver, ISO itp.
7

Russell, Kevin L., Margaret A. Ryan, Anthony Hawksworth, Nikki E. Freed, Marina Irvine, and Luke T. Daum. Effectiveness of the 2003/2004 Influenza Vaccine Among U.S. Military Basic Trainees: A Year of Suboptimal Match Between Vaccine and Circulating Strain. Fort Belvoir, VA: Defense Technical Information Center, June 2004. http://dx.doi.org/10.21236/ada455912.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Paris, Chloe, Julie Spencer, Lauren Castro, and Sara Del Valle. Exploring Impacts to COVID-19 Herd Immunity Thresholds Under Demographic Heterogeneity that Lowers Vaccine Effectiveness. Office of Scientific and Technical Information (OSTI), June 2022. http://dx.doi.org/10.2172/1874147.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Xu, Junjie, Jiaye Liu, Xinquan Lan, Moxin Song, Liangyuan Zhang, and Jiaqi Zhang. Efficacy of the third dose of COVID-19 vaccine: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0114.

Pełny tekst źródła
Streszczenie:
Review question / Objective: To investigate the immune response and related clinical outcomes of healthy adults who received coronavirus vaccine booster compared with those who did not receive the vaccine booster. Condition being studied: The COVID-19 pandemic, which has spread since 2019, has created a huge disease and economic burden on the world. A large number of clinical trials have verified the effectiveness of COVID-19 vaccine. Previous studies have found that the serum conversion rate and antibody level of those vaccinated after the first two doses of COVID-19 vaccine continue to decre
Style APA, Harvard, Vancouver, ISO itp.
10

Lamont, Susan J., E. Dan Heller, and Avigdor Cahaner. Prediction of Immunocompetence and Resistance to Disease by Using Molecular Markers of the Major Histocompatibility Complex. United States Department of Agriculture, September 1994. http://dx.doi.org/10.32747/1994.7568780.bard.

Pełny tekst źródła
Streszczenie:
This project utilized two live-animal populations in an integrated research program to identify molecular markers for immune response and disease resistance. The populations each had their foundation from meat-type commercial breeder chicken lines of their respective countries. Investigations effectively used unique availability of resources in each country to study commercial-type environments in Israel and line-crosses with diverse inbred lines in the US. Two bacterial systems were investigated to cover both respiratory and gastrointestinal, and primary and secondary, infections. Individual
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Vaccines Effectiveness” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii